Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone for Children With Autism Spectrum Disorder
NCT07635862Phase 2Not yet recruiting
- Sponsor
- Stanford University
- Start
- Jan 2027
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in Autism Spectrum Disorder (ASD), sponsored by Stanford University. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
ganaxolone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07635862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635862.